Popular Articles

Maharatna title likely tomorrow
The Cabinet is expected to clear tomorrow the proposal to grant the coveted "Maharatna status" to public sector blue-chips like ONGC, SAIL, BSNL, NTPC and CIL giving them increased autonomy.

Executives at top positions most corrupt: survey
Corruption is rampant in the Indian corporate sector and those at the top indulge the most in it, a majority of private employees surveyed have said.

News of the day

Top guns to sit on Air India intl advisory board
Air India (AI) is in the process of having a seven-member international advisory board, with former top officials of global carriers, to turn the organisation around.
Business Opportunities

Cipla rises 4.3%

The stock gained 4.3 per cent to close at an all-time high of Rs 345.30, on reports that the company is in talks with Pfizer, world’s largest drug maker, to supply generic products for their drugs. As an ongoing business strategy, the company is seeking alliance with other companies for developing products. - Sunny re-rating of pharma companies - Cipla shares jump on Pfizer talk - Cipla in talks with Pfizer, others for alliance - Pharma world discovers Bharat - F&O Outlook: Nifty may test new high before expiry - Nifty may test new high before expiry The company, which does not market its formulations directly in major markets like the US, follows a business partnership model of supplying products to about 14 drug companies around the world.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):